Search research articles
Contact Us
Filters
Showing results (31-40 of 61) with videos related to
Page
of 7
Sort By:
International Journal of Cancer
|
June 4, 1998
Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model
T M Behr, G Sgouros, V Vougiokas, et al.
Nuclear Medicine Communications
|
April 26, 2002
Follow-up of perfusion defects in pulmonary perfusion scanning after pulmonary embolism: are we too careless?
M Gotthardt, M Schipper, C Franzius, et al.
International Journal of Cancer
|
July 29, 1997
Selection of radioimmunoconjugates for the therapy of well-established or micrometastatic colon carcinoma
R M Sharkey, R D Blumenthal, T M Behr, et al.
Bioconjugate Chemistry
|
July 1, 1997
Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model
R M Sharkey, H Karacay, G L Griffiths, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 1997
Photopenia in chronic vertebral osteomyelitis with technetium-99m-antigranulocyte antibody (BW 250/183)
S Gratz, H G Braun, T M Behr, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 1, 1997
Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies
T M Behr, R M Sharkey, M E Juweid, et al.
Nuclear Medicine Communications
|
September 1, 1996
Thyroid radiation doses during radioimmunotherapy of CEA-expressing tumours with 131I-labelled monoclonal antibodies
T M Behr, M E Juweid, R M Sharkey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 30, 1999
Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential
T M Behr, M Béhé, C Angerstein, et al.
Cancer
|
July 1, 1996
Clinical evaluation of tumor targeting with the anticarcinoembryonic antigen murine monoclonal antibody fragment, MN-14 F(ab)2
M Juweid, R M Sharkey, T M Behr, et al.
Cancer Research
|
December 11, 1997
Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type
T M Behr, E Wulst, S Radetzky, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 61) with videos related to
Sort By:
Page
of 7
International Journal of Cancer
|
June 4, 1998
Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model
T M Behr, G Sgouros, V Vougiokas, et al.
Nuclear Medicine Communications
|
April 26, 2002
Follow-up of perfusion defects in pulmonary perfusion scanning after pulmonary embolism: are we too careless?
M Gotthardt, M Schipper, C Franzius, et al.
International Journal of Cancer
|
July 29, 1997
Selection of radioimmunoconjugates for the therapy of well-established or micrometastatic colon carcinoma
R M Sharkey, R D Blumenthal, T M Behr, et al.
Bioconjugate Chemistry
|
July 1, 1997
Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model
R M Sharkey, H Karacay, G L Griffiths, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 1997
Photopenia in chronic vertebral osteomyelitis with technetium-99m-antigranulocyte antibody (BW 250/183)
S Gratz, H G Braun, T M Behr, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 1, 1997
Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies
T M Behr, R M Sharkey, M E Juweid, et al.
Nuclear Medicine Communications
|
September 1, 1996
Thyroid radiation doses during radioimmunotherapy of CEA-expressing tumours with 131I-labelled monoclonal antibodies
T M Behr, M E Juweid, R M Sharkey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 30, 1999
Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential
T M Behr, M Béhé, C Angerstein, et al.
Cancer
|
July 1, 1996
Clinical evaluation of tumor targeting with the anticarcinoembryonic antigen murine monoclonal antibody fragment, MN-14 F(ab)2
M Juweid, R M Sharkey, T M Behr, et al.
Cancer Research
|
December 11, 1997
Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type
T M Behr, E Wulst, S Radetzky, et al.
Page
of 7